1. Cordis

    0 Comments Leave a Comment

    1-15 of 32 1 2 »
    1. Mentioned In 32 Articles

    2. A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel-eluting stents implantation

      A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel-eluting stents implantation
      ... and paclitaxel-eluting stents (PES). Methods: Consecutive patients undergoing elective PCI with SES (Cypher, Cordis) or PES (Taxus, Boston Scientific) were included in this single-centre, longitudinal study. OCT analysi...
      Read Full Article
    3. Frequency-Domain Optical Coherence Tomography Assessment of Stent Constriction 9 Months After Sirolimus-Eluting Stent Implantation in a Highly Calcified Plaque

      Frequency-Domain Optical Coherence Tomography Assessment of Stent Constriction 9 Months After Sirolimus-Eluting Stent Implantation in a Highly Calcified Plaque
      ...dtronic; he is also on the Speakers' Bureaus of and is a member of the Scientific Advisory Boards for Abbott, Cordis, St. Jude Medical, and Scitech. Dr. Attizzani has received consultant honoraria from St. Jude Medical. ...
      Read Full Article
    4. Multiple Interstrut Cavities Multiple Interstrut Cavities: A Potential Mechanism for Very Late Stent Thrombosis? Insights From Optical Coherence Tomography

      Multiple Interstrut Cavities Multiple Interstrut Cavities: A Potential Mechanism for Very Late Stent Thrombosis? Insights From Optical Coherence Tomography
      ...A 48-year-old man who had had a 3.5 33 mm sirolimus-eluting stent (Cypher, Cordis, Warren, New Jersey) deployed 46 months earlier for unstable angina, presented with a 1-h history of chest pain due to an anter...
      Read Full Article
    5. Identification of Vulnerable Plaque in a Stented Coronary Segment 17 Years after Implantation Using Optical Coherence Tomography

      Identification of Vulnerable Plaque in a Stented Coronary Segment 17 Years after Implantation Using Optical Coherence Tomography
      ...sis in the mid region. A guidewire was advanced into the LAD through a 6-Fr Judkin's Left 3.5 guide catheter (Cordis, Johnson and Johnson Co., Miami Lakes, FL, USA). Then, the OCT balloon catheter was advanced proximal t...
      Read Full Article
    6. Optical Coherence Tomography/Bioimaging: One decade and $500M: The impact of federal funding on OCT—Part 1

      Optical Coherence Tomography/Bioimaging: One decade and $500M: The impact of federal funding on OCT—Part 1
      ...lp retrieving data from databases: Russell Cox (EPSRC); Nancy Mendoza (BBRSC); the CORDIS Support Service (EC CORDIS); and Tiffany Lay (MRC)—as well as for permission to reproduce the data; also Yvonne Mason from AFOSR f...
      Read Full Article
    7. Thrombus Contribution to Very Late Restenosis of Bare-Metal Stent Treated by Excimer Laser Angioplasty: In Vivo Assessment with Optical Coherence Tomography

      Thrombus Contribution to Very Late Restenosis of Bare-Metal Stent Treated by Excimer Laser Angioplasty: In Vivo Assessment with Optical Coherence Tomography
      ...rick balloon (Boston Scientific, Natick, Massachusetts) and implantation of a sirolimus-eluting Cypher stent (Cordis Corporation, Miami, Florida) 3.5 x 23 mm were performed, with optimal angiographic result (Figure 1, Pa...
      Read Full Article
    8. 1-15 of 32 1 2 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Cordis

    Cordis

    Cordis is a medical device company owned by Johnson & Johnson. The company was founded in Miami, Florida in 1959.  Their products include stents, distal protection devices, catheters, and guidewires.